Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

CS-RfA-ETR (#RDB08362)

Backbone vector plasmid of shRNA expressing lentivirus construct by Gateway(R) cloning with TetR-2A-mRFP1 marker driven by EF-1 alpha promoter.

Clone info. Backbone vector plasmid of shRNA expressing lentivirus construct by Gateway(R) cloning with TetR-2A-mRFP1 marker driven by EF-1 alpha promoter.
Comment Commonly requested with pCMV-VSV-G-RSV-Rev (RDB04393) and pCAG-HIVgp (RDB04394).
Vector backbone CS-RfA-ETR ()
Selectable markers Ampicillin, Chloramphenicol, ccdB (E. coli). Please note that Zeo resistance marker is not included in the lentivirus produced from this vector.
Growth remarks Use DB3.1, ccdB Survival or equivalent to amplify this clone. 30 degC is fine.
Depositor|Developer Miyoshi, Hiroyuki |
 
Sequence RDB08362z.seq
Remarks, protocol and/or map (pdf) RDB08362.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose)[Word] [Example of MTA ]
Please visit Ordering instruction.[link] 
Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit academic purpose. The RECIPIENT agrees to expressly describe the late Dr. Hiroyuki Miyoshi as the Developer.
Remarks Remember that you will be working with samples containing infectious virus.
Use Survival2 (Invitrogen) or equivalent to amplify this clone.
This RESOURCE contains a fluorescent protein provided by Prof. Roger Tsien. UCSD's MTA is also required. Please visit Additional Forms section. This RESOURCE is not provided to for-profit organization or for for-profit research by non-profit organizations.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利機関による非営利学術研究用)[Word] [MTAの記入例 ]
遺伝子組換え生物の受入れ確認書が必要です。当室にご請求ください。
手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。
MTAに書く使用条件 本件研究材料は、非営利機関の非営利学術研究に限って提供する。本件研究材料を利用した研究結果等を発表する際は、本件研究材料が故三好浩之博士により開発されたことを明示する。
備考 【追加提供依頼書】受入れ確認書(書式J)
このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。
このクローンの増殖にはSurvival2 (Invitrogen)あるいは同等の宿主を使用してください。
Prof. Roger Tsienから供与された蛍光タンパク質を含みます。UCSDとのMTA締結が必要です。「申込みに必要な書式」をご覧ください。本件リソースは営利機関および非営利機関による営利目的研究には提供いたしません。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB08362 CS-RfA-ETR DNA solution

Ordering instruction of plasmids [in Japanese] [in English]
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The CS-RfA-ETR was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB08362).

Reference section:

Suga, H., Kadoshima, T., Minaguchi, M., Ohgushi, M., Soen, M., Nakano, T., Takata, N., Wataya, T., Muguruma, K., Miyoshi, H., Yonemura, S., Oiso, Y., Sasai, Y., Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480 (7375): 57-62 (2011). PMID 22080957. [link to RRC of NBRP]

Further references such as user reports and related articles (go to bottom)

QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB12396_A4Avp1-2.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: Cm_M_R (Pr0012)
Region: CmR,attR1,cPPT_CTS
Sequence file: RDB12396_A4Ava.seq check
>08362_12396_B2E9F_Cm_M_R_D01_04_ABI08.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNNNATNN CCNGCTCNCC GTCTTTCNTT GCCNTACGGA
   61 ATTCCGGATG AGCATTCATC AGGCGGGCAA GAATGTGAAT AAAGGCCGGA TAAAACTTGT
  121 GCTTATTTTT CTTTACGGTC TTTAAAAAGG CCGTAATATC CAGCTGAACG GTCTGGTTAT
  181 AGGTACATTG AGCAACTGAC TGAAATGCCT CAAAATGTTC TTTACGATGC CATTGGGATA
  241 TATCAACGGT GGTATATCCA GTGATTTTTT TCTCCATTTT AGCTTCCTTA GCTCCTGAAA
  301 ATCTCGACGG ATCCTAACTC AAAATCCACA CATTATACGA GCCGGAAGCA TAAAGTGTAA
  361 AGCCTGGGGT GCCTAATGCG GCCGCCATAG TGACTGGATA TGTTGTGTTT TACAGTATTA
  421 TGTAGTCTGT TTTTTATGCA AAATCTAATT TAATATATTG ATATTTATAT CATTTTACGT
  481 TTCTCGTTCA GCTTTTTTGT ACAAACTTGT GATAATTCAA AGTGAATTTC TGCTGTCCCT
  541 GTAATAAACC CGAAAATTTT GAATTTTTGT AATTTGTTTT TGTAATTCTT TAGTTTGTAT
  601 GTCTGTTGCT ATTATGTCTA CTATTCTTTC CCCTGCACTG TACCCCCCAA TCCCCCCTTT
  661 TCTTTTAAAA TTGTGGATGA ATACTGCCAT TTGTAGATCC GTTCACTAAT CGAATGGATC
  721 TGTCTCTGTC TCTCTCTCCA CCTTCTTCTT CTATTCCTTC GGGCCTGTCG GGTCCCCTCG
  781 GGGTTGGGAG GTGGGTCTNN NNNATANTGG TGAATATCCC TGCCTANNTC TATTCACTAT
  841 AGAAAGTACA GCAAAAACTA TTCTTAAACC NNCCAAGCCN NCNTACTATC ANTATGANTA
  901 ATTTTATATA NNACAGCNAA TTTGTTATGN NNANNCNNNT CCNNNAACTT GCCCNNTTAT
  961 CNNANTTCNN ATANNTCTTG NNCNTTNTTT TCNTGNTGGN TTTGNNANNC NTNNANNNAN
 1021 NNNNNGNNNT NNNCNTNGNG TANNNGNNNN NTNCNNNGNC CNNNNNNNNN CNNNTNNNGN
1081 NANTNCNNNN NNGNTNNNNN NNNTNNNNNN NNNN
//
Primer: EF1a-N_R (Pr0024)
Region: EF-1 alpha pro,attR2,ccdB
Sequence file: RDB12396_A4Avb.seq check
>08362_12396_B2E9F_EF1a-N_R_E01_05_ABI08.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNGCGCT CTGCCNNCTG ACGGGCACCG
   61 GANCCTCACG AAGCTTGAAT TATCACCACT TTGTACAAGA AAGCTGAACG AGAAACGTAA
  121 AATGATATAA ATATCAATAT ATTAAATTAG ATTTTGCATA AAAAACAGAC TACATAATAC
  181 TGTAAAACAC AACATATCCA GTCACTATGG TCGACCTGCA GACTGGCTGT GTATAAGGGA
  241 GCCTGACATT TATATTCCCC AGAACATCAG GTTAATGGCG TTTTTGATGT CATTTTCGCG
  301 GTGGCTGAGA TCAGCCACTT CTTCCCCGAT AACGGAGACC GGCACACTGG CCATATCGGT
  361 GGTCATCATG CGCCAGCTTT CATCCCCGAT ATGCACCACC GGGTAAAGTT CACGGGAGAC
  421 TTTATCTGAC AGCAGACGTG CACTGGCCAG GGGGATCACC ATCCGTCGCC CGGGCGTGTC
  481 AATAATATCA CTCTGTACAT CCACAAACAG ACGATAACGG CTCTCTCTTT TATAGGTGTA
  541 AACCTTAAAC TGCATTTCAC CAGCCCCTGT TCTCGTCAGC AAAAGAGCCG TTCATTTCAA
  601 TAAACCGGGC GACCTCAGCC ATCCCTTCCT GATTTTCCGC TTTCCAGCGT TCGGCACGCA
  661 GACGACGGGC TTCNNTCTGC ATGGTTGTGC TTACCNGACC GGNNNNNNTG ACATCATATA
  721 TGCCTTGAGC AACTGATAGC TGTCGCTGTC NACTGTCACT GTAATACGCT GCTTCATAGC
  781 ATACCTCTTT TTGACATACT TCGGGTATAC ATATCAGTAT ATATTCTTAN ACCGCAAAAN
  841 TCNNCGCGCA AATANNNNTN CTGTTATCTG GCTTTTANTA ANNCGGANCC NCGCGTTTAC
  901 NCCCCGNCNN NNNNCTCNTC GNAGNANTGT TGNAANTCNN TAANNNTTCT NNNNANATGG
  961 AANCNNTCNC NNCNGCATGN NNNANCNTGA ATCNCCNGCG GCNTCNNCNN NNTGNNNNCN
 1021 NGCGNANAAN ATTTGNNNNN GNNAAAANNG GGGNNNNNNN NNGNNCNNNN NGNNCNNNNN
1081 NNNANNNNNN NNNN
//
Primer: EF1a-C_F (Pr0168)
Region: EF-1 alpha pro,TetR,T2A
Sequence file: RDB12396_A4Avc.seq check
>08362_12396_B2E9F_EF1a-C_F_E03_15_ABI24.ab1
    1 NNNNNNNNNN NNTTTTNAGT TTGGNNCTTG GTTCNTTCTC NAGCCTCAGA CAGTGGTTCA
   61 AAGTTTTTTT CTTCCNTTTC AGGTGTCGTG AATTAATTAA CCGGCCGCAT AAGGTGGCGG
  121 TGGCAGCTAG ACTAGCGCTA CCGGTCGCCA CCATGTCTAG ATTAGATAAA AGTAAAGTGA
  181 TTAACAGCGC ATTAGAGCTG CTTAATGAGG TCGGAATCGA AGGTTTAACA ACCCGTAAAC
  241 TCGCCCAGAA GCTAGGTGTA GAGCAGCCTA CATTGTATTG GCATGTAAAA AATAAGCGGG
  301 CTTTGCTCGA CGCCTTAGCC ATTGAGATGT TAGATAGGCA CCATACTCAC TTTTGCCCTT
  361 TAGAAGGGGA AAGCTGGCAA GATTTTTTAC GTAATAACGC TAAAAGTTTT AGATGTGCTT
  421 TACTAAGTCA TCGCGATGGA GCAAAAGTAC ATTTAGGTAC ACGGCCTACA GAAAAACAGT
  481 ATGAAACTCT CGAAAATCAA TTAGCCTTTT TATGCCAACA AGGTTTTTCA CTAGAGAATG
  541 CATTATATGC ACTCAGCGCT GTGGGGCATT TTACTTTAGG TTGCGTATTG GAAGATCAAG
  601 AGCATCAAGT CGCTAAAGAA GAAAGGGAAA CACCTACTAC TGATAGTATG CCGCCATTAT
  661 TACGACAAGC TATCGAATTA TTTGATCACC AAGGTGCAGA GCCAGCCTTC TTATTCGGCC
  721 TTGAATTGAT CATATGCGGA TTAGAAAAAC AACTTAAATG TGAAAGTGGG TCCGCGTACA
  781 GCGGATCCGG CGANGGCAGA NGAAGTCTTC TAACATGCGG TGACGTGGAN GAAAATCCCG
  841 GGCCNATGGC CTCCTCCGAG GANGTCNTCA AGGAGTTCAT GCGCTTCNAG GTGNGCATGG
901 NNGGNTNCGT GAACGGCNNN NANTNNNNNN NNNN
//
Primer: PRE_rev (Pr0250)
Region: PRE,mRFP1 3'
Sequence file: RDB12396_A4Avd.seq check
>08362_12396_B2E9F_PRE_rev_F01_06_ABI08.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNC NACNTAGTTA AGAATACCNG TCAATCTTTC
   61 NCAAATTTTG TAATCCAGAG GTTGATTATC GATAAGCTTG ATCCCTCGAG TGCGGCCGCT
  121 TAGGCGCCGG TGGAGTGGCG GCCCTCGGCG CGCTCGTACT GTTCCACGAT GGTGTAGTCC
  181 TCGTTGTGGG AGGTGATGTC CAGCTTGATG TCGGTCTTGT AGGCGCCGGG CAGCTGCACG
  241 GGCTTCTTGG CCATGTAGGT GGTCTTGACC TCGGCGTCGT AGTGGCCGCC GTCCTTCAGC
  301 TTCAGCCTCA TCTTGATCTC GCCCTTCAGG GCGCCGTCCT CGGGGTACAT CCGCTCGGTG
  361 GAGGCCTCCC AGCCCATGGT CTTCTTCTGC ATTACGGGGC CGTCGGAGGG GAAGTTGGTG
  421 CCGCGCAGCT TCACCTTGTA GATGAACTCG CCGTCCTGCA GGGAGGAGTC CTGGGTCACG
  481 GTCACCACGC CGCCGTCCTC GAAGTTCATC ACGCGCTCCC ACTTGAAGCC CTCGGGGAAG
  541 GACAGCTTCA AGTAGTCGGG GATGTCGGCG GGGTGCTTCA CGTAGGCCTT GGAGCCGTAC
601 TGGAACTGAG GGGACAGGAT GTCCCAGGCG AAGGNN
//
Primer: CMV_Forward (Pr0016)
Region: 5' LTR,HIV-1 psi
Sequence file: RDB12396_A4Ave.seq check
>08362_12396_A4Av_1_CMV-Foward_C10_07.ab1
    1 NNNNNNNNNN NNNNNNNNNN TTGNNNCAAA TGGGCGGTAG GCGTGTNCGG TGGGAGGTCT
   61 ATATAAGCAG CGCGTTNNNN NNGTACTGGG TCTCTCTGGT TAGACCAGAT CTGAGCCTGG
  121 GAGCTCTCTG GCTAACTAGG GAACCCACTG CTTAAGCCTC AATAAAGCTT GCCTTGAGTG
  181 CTTCAAGTAG TGTGTGCCCG TCTGTTGTGT GACTCTGGTA ACTAGAGATC CCTCAGACCC
  241 TTTTAGTCAG TGTGGAAAAT CTCTAGCAGT GGCGCCCGAA CAGGGACTTG AAAGCGAAAG
  301 GGAAACCAGA GGAGCTCTCT CGACGCAGGA CTCGGCTTGC TGAAGCGCGC ACGGCAAGAG
  361 GCGAGGGGCG GCGACTGGTG AGTACGCCAA AAATTTTGAC TAGCGGAGGC TAGAAGGAGA
  421 GAGATGGGTG CGAGAGCGTC AGTATTAAGC GGGGGAGAAT TAGATCGCGA TGGGAAAAAA
  481 TTCGGTTAAG GCCANNGNNA AAGAAAAAAT ATAAATTAAA ACATATAGTA TGGGCAAGCA
  541 GGGAGCTAGA ACGATTCGCA GTTAATCCTG GCCTGTTAGA AACATCAGAA GGCTGTAGAC
  601 AAATACTGGG ACAGCTACNA CCATCCCTTC AGACAGGATC AGAAGAACTT AGATCATTAT
  661 ATAATACAGT AGCAACCCTC TATTGTGTGC ATCAAAGGAT AGAGATAAAA GACACCAAGG
  721 AAGCTTTAGA CAAGATAGAG GAAGAGCAAA ACAAAAGTAA GACCACCGCA CAGCAAGCGG
  781 CCGCTGATCT TCAGACCTGG AGGAGGAGAT ATGANGGANA NTTGGAGAAN TGAATTATAT
  841 AAATATAAAG TAGTAAAAAT TGAACCNTTA NGAGTAGCNN CCANNNANGG CAAAGAGAAG
  901 ANTGGTGCAN ANAGAAAAAA GANCAGTGGN NNTAGGANCT TTGTNNCNNG GGNNCTNGGG
  961 NNCANCNNNA GCACTNTGGG CGCANCGNNN NTGNNNCTGN NGNTACNNGC NNNNNNNNNN
//
Primer: mRFP-M_R (Pr0674)
Region: mRFP 5',T2A,TetR
Sequence file: RDB12396_A4Avf.seq check
>08362_12396_B2E9F_mRFP-M_R_F01_06_ABI08.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NGNNCCGNAN TGGAACNNGA NGGGNNNGGN
   61 TGTCCNAGGC GAAGGGCAGG GGGCCGCCCT TGGTCACCTT CAGCTTGGCG GTCTGGGTGC
  121 CCTCGTAGGG GCGGCCCTCG CCCTCGCCCT CGATCTCGAA CTCGTGGCCG TTCACGGAGC
  181 CCTCCATGCG CACCTTGAAG CGCATGAACT CCTTGATGAC GTCCTCGGAG GAGGCCATAG
  241 GCCCGGGATT TTCCTCCACG TCACCGCATG TTAGAAGACT TCCTCTGCCC TCGCCGGATC
  301 CGCTGTACGC GGACCCACTT TCACATTTAA GTTGTTTTTC TAATCCGCAT ATGATCAATT
  361 CAAGGCCGAA TAAGAAGGCT GGCTCTGCAC CTTGGTGATC AAATAATTCG ATAGCTTGTC
  421 GTAATAATGG CGGCATACTA TCAGTAGTAG GTGTTTCCCT TTCTTCTTTA GCGACTTGAT
  481 GCTCTTGATC NTCCAATACG CAACCTAAAG TAAAATGCCC CANNNNGCTG AGTGCATATA
  541 ATGCNNTCTC TAGTGAAAAA CCTTGTNGNN NNAAAAAGGC TAATTGATTT TCNAGAGTTT
  601 CATACTGTTN NNNNNTANGC CGTGTACCTA AATGTACTTT TGNNNNNTCG CGANNANNTN
  661 NNNNNGCNCN NNNNNNNNTN NNNNNGNNAN NNNNNAAAAA NNNNNGCCAG CTTTNNNNNN
721 CTNNNNGGNN NNNNNGNNNN NNNNGNNNNT CTNNNNNCNN NNNNNN
//
Primer: BGH_rev2 (Pr0606)
Region: bGH pA,3' LTR
Sequence file: RDB12396_A4Avg.seq check
>08362_12396_B2E9F_BGH_rev2_H01_08_ABI08.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNGG NNNGGGCNNA CNACNGATGG CTGGCAACTA
   61 GAAGGCACAG TCGAGGCTGA TCAGCGGGTT TAAACGGGCC CTGCTAGAGA TTTTCCACAC
  121 TGACTAAAAG GGTCTGAGGG ATCTCTAGTT ACCAGAGTCA CACAACAGAC GGGCACACAC
  181 TACTTGAAGC ACTCAAGGCA AGCTTTATTG AGGCTTAAGC AGTGGGTTCC CTAGTTAGCC
  241 AGAGAGCTCC CAGGCTCAGA TCTGGTCTAA CCAGAGAGAC CCAGTACAGT CCGGATGCAG
  301 CTCTCGGGCC ATGTGATGAA ATGCTAGGCG GCTGTCAAAC CTCCACTCTA ATACTTCTCT
  361 CTCCGGGTCA TCCATCCCAT GCAGGCTCAC AGGGTGTAAC AAGCGGGTGT TCTCTCCTTC
  421 ATTGGCTTCT TCTACCTTCT CTTGCTCAAC TGGTACTAGC TTGTAGCACC ATCCAAAGGT
  481 CAGTGGATAT CTGATCCCTG GCCCTGGTGT GTAGTTCTGC CAATCAGGGA AGTAGCCTTG
  541 TGTGTGGTAG ATCCACAGAT CAAGGATATC TTGTCTTCGT TGGGAGTGAA TTAGCCCTTC
  601 CAGTCCCCCC TTTTCTTTTA AAAAGTGGCT AAGATCTACA GCTGCCTTGT AAGTCATTGG
  661 TCTTAAAGGT ACCTGAGGTG TGACTGGAAA ACCCACCTCC TCCTCCTCTT GTGCTTCTAG
  721 CCAGGCACAA TCAGCATTGG NNNNNGCTGT NNTGCNNNTT GTGATTGCTC CNNTGTTTTT
  781 CNAGGNCTCG ACGGNATCGA TGCGGGNAGG CGGNCCAAAG GGAGATCCNN ANTCNNCTGA
841 NGGNNAANGC GAANACNCNG NANNANNNNN CANANNNNGN NNCNNNNNN
//
Primer: SV40pro_F (Pr0110)
Region: Zeo,SV40 pA
Sequence file: RDB12396_A4Avh.seq check
>08362_12396_A4Av_1_SV40pro_F_G05_20.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNT GNNGNNGNTT TTTTGGAGGC CNANNNTTTT
   61 GCAAAAAGCT CCCGGGNGCN NNNNNNNNNN NNNNNGATCT GATCAGCACG TGTTGACAAT
  121 TAATCNTCGG CATAGTATAT CGGCATAGTA TAATACGACA AGGTGAGGAA CTAAACCATG
  181 GCCAAGTTGA CCAGTGCCGT TCCGGTGCTC ACCGCGCGCG ACGTCGCCGG AGCGGTCGAG
  241 TTCTGGACCG ACCGGCTCGG GTTCTCCCGG GACTTCGTGG AGGACGACTT CGCCGGTGTG
  301 GTCCGGGACG ACGTGACCCT GTTCATCAGC GCGGTCCAGG ACCAGGTGGT GCCGGACAAC
  361 ACCCTGGCCT GGGTGTGGGT GCGCGGCCTG GACGAGCTGT ACGCCGAGTG GTCGGAGGTC
  421 GTGTCCACGA ACTTCCGGGA CGCCTCCGGG CCGGCCATGA CCGAGATCGG CGAGCAGCCG
  481 TGGGGGCGGG AGTTCGCCCT GCGCGACCCG GCCGGCAACT GCGTGCACTT CGTGGCCGAG
  541 GAGCAGGACT GACACGTGCT ACGAGATTTC GATTCCACCG CCGCCTTCTA TGAAAGGTTG
  601 GGCTTCGGAA TCGTTTTCCG GGACGCCGGC TGGATGATCC TCCAGCGCGG GGATCTCATG
  661 CTGGAGTTCT TCGCCCACCC CAACTTGTTT ATTGCAGCTT ATAATGGTTA CAAATAAAGC
  721 AATAGCATCA CAAATTTCAC AAATAAAGCA TTTTTTTCAC TGCATTCTAG TTGTGGTTTG
  781 TCCAAACTCA TCAATGTATC TTATCATGTC TGTATACCGT CNANCTCTAG CTAGAGCTTG
  841 GCGTAATCAT GGGTCATANC TGTTTCCTGT GTGAAATTGT TATCCGCTCA CAATTCCACA
  901 CAACATACGA GCCGGAANCN TAANNTGTAA AGCNTGGGGN GNCNAANGAG TGANCTNACN
  961 NACATTNNTT GCGTTGCGCT CACNGNNNNC TTTNCNNNCG GGNAANNNGN NNNGNNNNCN
1021 NCNNNNANTG AATCNNNNNN NNCNNNGGNN NNNNNNNGNN NNNNNNNTNN NNNNNNNN
//

Please visit Sequencing and PCR primers for primer information.

References

Original, user report and related articles

original Suga, H., Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480 (7375): 57-62 (2011). PMID 22080957. [link to RRC of NBRP]
reference Takata, N., Establishment of Functional Genomics Pipeline in Epiblast-Like Tissue by Combining Transcriptomic Analysis and Gene Knockdown/Knockin/Knockout, Using RNA Interference and CRISPR/Cas9. Hum. Gene Ther. 27 (6): 436-450 (2016). PMID 26839115.
user_report Noura, M., NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation. 29 Oct 2023, PREPRINT (Version 1) available at Research Square https://doi.org/10.21203/rs.3.rs-3498291/v1
user_report Matsui, Y., Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation. Biochem. Biophys. Res. Commun. 620: 150-157 (2022). PMID 35792512. [link to RRC of NBRP]
user_report Morita, K., RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice. Blood Adv. 2 (5): 509-515 (2018). PMID 29500219. [link to RRC of NBRP]
user_report Morita, K., Genetic regulation of the RUNX transcription factor family has antitumor effects. J. Clin. Invest. 127 (7): 2815-2828 (2017). PMID 28530640. [link to RRC of NBRP]
user_report Morita, K., Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells. Sci. Rep. 7 (1): 16604 (2017). PMID 29192243. [link to RRC of NBRP]
user_report Morita, K., Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions. Blood Adv. 1: 1440-1451 (2017). PMID 29296785. [link to RRC of NBRP]